Application 020808
- Type
- NDA
- Sponsor
- GE HEALTHCARE
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | VISIPAQUE 270 | IODIXANOL | INJECTABLE;INJECTION | 55% | No | No |
| 002 | VISIPAQUE 320 | IODIXANOL | INJECTABLE;INJECTION | 65.2% | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| N020808-001 | VISIPAQUE 270 | IODIXANOL | 55% | INJECTABLE / INJECTION | 1997-08-29 | ||
| N020808-002 | VISIPAQUE 320 | IODIXANOL | 65.2% | INJECTABLE / INJECTION | 1997-08-29 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 74a2ff9319b5… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | bb7c543d1eb4… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 782e0a99824c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 87673890dc5c… | ||
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 87673890dc5c… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 5aa47cf7b7d7… | ||
| 2021-03-12 10:30 UTC | 2021-03 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 5aa47cf7b7d7… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 8869cabd3fbd… | ||
| 2020-12-22 03:56 UTC | 2020-12 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 8869cabd3fbd… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | c0c555d07b60… | ||
| 2020-11-12 02:37 UTC | 2020-11 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | c0c555d07b60… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 3f01610625f2… | ||
| 2019-12-14 00:12 UTC | 2019-12 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 3f01610625f2… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | b00525d2431f… | ||
| 2019-09-15 20:21 UTC | 2019-09 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | b00525d2431f… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | ea99ee380514… | ||
| 2019-07-19 19:46 UTC | 2019-07 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | ea99ee380514… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 6a51e52b5d6a… | ||
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 6a51e52b5d6a… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 1c564ffb4f44… | ||
| 2024-02-18 07:12 UTC | 2024-02 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 1c564ffb4f44… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | ea1830bbd6c7… | ||
| 2023-12-20 04:57 UTC | 2023-12 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | ea1830bbd6c7… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | a72a2bbeb626… | ||
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | a72a2bbeb626… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 9b2671bbb829… | ||
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 9b2671bbb829… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | a67488948f0b… | ||
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | a67488948f0b… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 3f0d92c62455… | ||
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 3f0d92c62455… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 053a50430f4f… | ||
| 2023-05-13 08:27 UTC | 2023-05 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 053a50430f4f… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 3bdfa0b2c4d7… | ||
| 2023-01-26 05:58 UTC | 2023-01 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 3bdfa0b2c4d7… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020808-001 | VISIPAQUE 270 | 55% | INJECTABLE / INJECTION | 1997-08-29 | 3a93d1ddd44b… | ||
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | N020808-002 | VISIPAQUE 320 | 65.2% | INJECTABLE / INJECTION | 1997-08-29 | 3a93d1ddd44b… |
Observed Orange Book exclusivity history#
| Captured | Edition | Application-product | Exclusivity code | Expiration | Source SHA-256 |
|---|---|---|---|---|---|
| 2019-12-13 00:20 UTC | 2019-12 | N020808-002 | I-752 | 2020-04-05 | 74a2ff9319b5… |
| 2020-12-22 03:56 UTC | 2020-12 | N020808-002 | I-752 | 2020-04-05 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | N020808-002 | I-752 | 2020-04-05 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | N020808-002 | I-752 | 2020-04-05 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | N020808-002 | I-752 | 2020-04-05 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | N020808-002 | I-752 | 2020-04-05 | ea99ee380514… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Visipaque | IODIXANOL | GE Healthcare Inc. | 2d964c13-88ad-43be-88d4-a3a7ea4d5b5e | 2025-10-17 | Boxed warning, Warnings, Adverse reactions | 020808 NDA020808 0407-2223 |
| Visipaque | IODIXANOL | GE Healthcare Inc. | e9d87b8c-7695-4c0f-8e81-000dedb5f66d | 2025-10-10 | Boxed warning, Warnings, Adverse reactions | 0407-2223 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 0407-2223 | Visipaque | Iodixanol | GE Healthcare Inc. | NDA | Current |
| 0407-2223 | Visipaque | Iodixanol | GE Healthcare Inc. | NDA | Current |
| 0407-2223 | Visipaque | Iodixanol | GE Healthcare Inc. | NDA | Current |
| 0407-2223 | Visipaque | Iodixanol | GE Healthcare Inc. | NDA | Current |
Documents#
| Document | Submission type | Date |
|---|---|---|
| 74086 | SUPPL | 2023-04-27 |
| 74080 | SUPPL | 2023-04-27 |
| 70252 | SUPPL | 2022-02-24 |
| 58920 | SUPPL | 2019-06-03 |
| 57992 | SUPPL | 2019-03-14 |
| 57980 | SUPPL | 2019-03-13 |
| 47957 | SUPPL | 2017-04-12 |
| 47943 | SUPPL | 2017-04-12 |
| 47900 | SUPPL | 2017-04-07 |
| 47895 | SUPPL | 2017-04-07 |
| 3399 | SUPPL | 2015-07-10 |
| 35390 | SUPPL | 2015-07-09 |
| 41715 | SUPPL | 2004-06-30 |
| 35389 | SUPPL | 2003-12-29 |
| 25880 | SUPPL | 2003-12-23 |
| 25879 | SUPPL | 2003-09-25 |